Treatment of Ureaplasma spp Infections

First-Line Treatment Options

The American College of Physicians recommends doxycycline 100 mg orally twice daily for 7 days as the most effective first-line treatment for Ureaplasma spp infections 1
Doxycycline is particularly effective for Ureaplasma urealyticum infections, which is recognized as an etiological agent in non-gonococcal urethritis (NGU) 2

Azithromycin 1.0-1.5 g orally as a single dose is an effective alternative treatment option for Ureaplasma urealyticum infections 1
Erythromycin base 500 mg orally four times a day for 7 days is an alternative option for treating Ureaplasma infections 1
Levofloxacin 500 mg orally once daily for 7 days is an alternative option for treating Ureaplasma infections 1
Ofloxacin 300 mg orally twice a day for 7 days is an alternative option for treating Ureaplasma infections 1

For patients who fail initial doxycycline therapy, azithromycin 500 mg orally on day 1, followed by 250 mg daily for 4 days is recommended 1
After azithromycin failure, moxifloxacin 400 mg orally once daily for 7-14 days is recommended 1, 3
For tetracycline-resistant infections, moxifloxacin 400 mg once daily for 7-14 days is the preferred second-line treatment 3
Pristinamycin 1 g four times daily for 10 days can be used as a third-line option after moxifloxacin failure, with a cure rate of approximately 75% 3

Perform a validated nucleic acid amplification test (NAAT) on a first-void urine sample or urethral smear before empirical treatment to confirm diagnosis 4
In patients with mild symptoms, it is advisable to delay treatment until guided by the results of the nucleic acid amplification tests 2
The role of Ureaplasma spp. in causing urethritis has been debated, with recent data suggesting that U. urealyticum, but not U. parvum, is an etiological agent in NGU 2

Sexual partners should be evaluated and treated to prevent reinfection 1
Treatment of partners with last sexual contact within 60 days of diagnosis is recommended 1
Patients and partners should abstain from sexual intercourse until therapy is completed and symptoms have resolved 1

Patients should return for evaluation if symptoms persist or recur after completing therapy 1
Objective signs of urethritis should be present before initiating additional antimicrobial therapy 1

HIV-infected patients should receive the same treatment regimens as HIV-negative patients 1

Doxycycline remains the most reliable first-line agent with consistent efficacy against Ureaplasma species 1